| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 08:30 | Knowit AB: Knowit Expands Collaboration with Equinor on Advanced Sensor Technology | 148 | Knowit has entered into a new three-year agreement with Equinor for the further development and operation of the company's platform for Distributed Fiber Optic Sensing (DFOS). The agreement marks an... ► Artikel lesen | ||
| 08:10 | ING Group: Progress on share buyback programme | 239 | Progress on share buyback programme
ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 2,767,892 shares were repurchased during... ► Artikel lesen | ||
| 08:06 | Caledonia Mining Corporation Plc: Publication and Highlights of the Feasibility Study for Bilboes Gold Project | 161 | ST HELIER, Jersey, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) is pleased to announce the decision... ► Artikel lesen | ||
| 08:06 | WENDEL: Signing of the acquisition agreement of Committed Advisors | 66 | Signing of the acquisition agreement of Committed Advisors Wendel announced on October 24, 2025, that it had entered into exclusive negotiations to acquire a controlling stake in Committed Advisors... ► Artikel lesen | ||
| 08:00 | ACROUD AB: Acroud publishes interim report July-September 2025 | 91 | Financial highlights during third quarter 2025• Revenue amounted to EUR 13,033 (9,240) thousand, an increase of 41% compared with the previous year.
• Adjusted EBITDA (before items affecting comparability)... ► Artikel lesen | ||
| 08:00 | Beijer Ref AB: Beijer Ref completes acquisition of Airwave | 75 | Press release
Beijer Ref has completed the transaction of Airwave, a leading HVAC distributor in the Baltic region. In October 2025, Beijer Ref signed a binding agreement to acquire 80 per cent of the... ► Artikel lesen | ||
| 08:00 | QPR Software: Santander Bank Poland chooses QPR Software as its Process Mining Partner | 52 | QPR SOFTWARE PLC PRESS RELEASE 25 November 2025 at 9 AM EETSantander Bank Poland has selected QPR Software as its process mining partner and will implement the QPR ProcessAnalyzer solution.... ► Artikel lesen | ||
| 08:00 | Terranet AB: Last day of trading with unit rights in Terranet's rights issue | 161 | Today, 25 November 2025, is the last day of trading in the unit rights issued in connection with the rights issue of units consisting of shares with preferential rights for existing shareholders which... ► Artikel lesen | ||
| 07:36 | Mowi ASA - Green Bond Mandate Announcement and Fixed Income Investor Meetings | 85 | Bergen, 25 November 2025. Mowi ASA, investment grade rated BBB+ with stable outlook by Nordic Credit Rating, has mandated Danske Bank, DNB Carnegie and Nordea as Global Coordinators and Joint Lead... ► Artikel lesen | ||
| 07:34 | Sampo plc's share buybacks 24 November 2025 | 160 | Sampo plc, stock exchange release, 25 November 2025 at 8:30 am EET
Sampo plc's share buybacks 24 November 2025
On 24 November 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22)... ► Artikel lesen | ||
| 07:30 | Fortum: Fortum updates its long-term financial targets, strategic targets and strategic KPIs | 99 | FORTUM CORPORATION INVESTOR NEWS 25 NOVEMBER 2025 AT 8:30 EET
Fortum updates its long-term financial targets, strategic targets and strategic KPIs. Fortum adds comparable RONA (return on net assets)... ► Artikel lesen | ||
| 07:30 | TCM Group A/S: Interim report Q3 2025 | 71 | COMPANY ANNOUNCEMENT No. 246/2025 Tvis, 25 November 2025 Interim report Q3 2025 (July 1 - September 30) (All figures in brackets refer to the corresponding period in 2024) Delivering stable... ► Artikel lesen | ||
| 07:22 | Novartis Pharma AG: Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS | 237 | Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids to be presented as late-breakerScemblix data across clinical and real-world settings offer... ► Artikel lesen | ||
| 07:10 | Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025 | 212 | Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025
Halle
To join the conference call via phone, participants may pre-register and will... ► Artikel lesen | ||
| 07:10 | dsm-firmenich: Weekly progress on share repurchase program to cover share plans and reduce capital | 167 | Press Release
Weekly progress on share repurchase program to cover share plans and reduce capital
Kaiseraugst (Switzerland), Maastricht (Netherlands), November 25, 2025
dsm-firmenich, innovators... ► Artikel lesen | ||
| 07:10 | Sanofi: Sanofi and Regeneron's Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria | 295 | Sanofi and Regeneron's Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Approval based on phase 3 studies showing Dupixent significantly... ► Artikel lesen | ||
| 07:10 | ABN AMRO presents roadmap for profitable growth and new financial targets for 2028 | 259 | ABN AMRO presents roadmap for profitable growth and new financial targets for 2028
25 November 2025
Today, ABN AMRO presents the bank's new strategy and financial outlook for 2026-2028 at its... ► Artikel lesen | ||
| 07:10 | ABN AMRO to sell Alfam to Rabobank | 262 | ABN AMRO to sell Alfam to RabobankPersonal loans offered via a third-party arrangement25 November 2025Today, ABN AMRO announces that it has reached an agreement on the sale of its fully-owned subsidiary... ► Artikel lesen | ||
| 07:06 | Sanoma Corp: Sanoma updates its financial targets - aims to deliver high single-digit growth in the Group's adjusted operating profit in 2026-2030 | 238 | Sanoma Corporation, Stock Exchange Release, 25 November 2025 at 8:00 a.m. EET Sanoma updates its financial targets - aims to deliver high single-digit growth in the Group's adjusted operating profit... ► Artikel lesen | ||
| 07:06 | Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU) | 105 | Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years... ► Artikel lesen | ||
| 07:00 | Egetis Therapeutics AB: Interim report Q3 2025 | 40 | Egetis to commence a rolling NDA submission in December as granted by the FDA for Emcitate® (tiratricol)· Egetis received FDA Breakthrough Therapy Designation for Emcitate® (tiratricol) for... ► Artikel lesen | ||
| 07:00 | Admicom Oyj: Admicom announces new growth strategy, mid-term financial targets and revised dividend policy | 38 | Admicom Oyj Company release November 25, 2025 at 8:00 EET
Admicom Oyj's Board of Directors has approved the company's updated strategy and mid-term financial targets for the period 2026-2028. In addition... ► Artikel lesen | ||
| 07:00 | Alimak Group: Alimak Group sets new financial and sustainability targets valid through 2028 | 63 | Alimak Group has set new financial and sustainability targets as the Group enters the next phase of its strategic growth journey.
Launched in 2020, the New Heights programme has over the past five years... ► Artikel lesen | ||
| 05:36 | Central Iron Ore Limited Results of the Shareholders Meeting | 32 | VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Central Iron Ore Limited (CIO - TSX.V) ("CIO" or "the Company") is pleased to announce the results of its annual meeting of shareholders... ► Artikel lesen | ||
| 03:06 | Nokia Oyj: Nokia introduces MantaRay SON to NTT DOCOMO's multi-vendor 5G network | 77 | Nokia introduces MantaRay SON to NTT DOCOMO's multi-vendor 5G network Nokia and NTT DOCOMO partner to revolutionize 5G Operations in Japan with MantaRay SONAutonomous solution enhances 5G network... ► Artikel lesen |